Orchestra BioMed Holdings (OBIO) FCF Margin (2022 - 2026)
Orchestra BioMed Holdings (OBIO) reported FCF Margin of 20320.0% for Q1 2026, down 1839281.0% year-over-year from N/an in Q1 2025, and down 316709.6% on a QoQ basis from 6.41% in Q4 2025.
Orchestra BioMed Holdings (OBIO) has 5 years of FCF Margin data on file, last reported at 20320.0% in Q1 2026.
- Quarterly FCF Margin fell 1839281.0% year-over-year to 20320.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 167.33% (up 171604.0% YoY) and the FY2025 annual result came in at 146.74%, up 178074.0% from the prior year.
- FCF Margin fell to 20320.0% in Q1 2026 per OBIO's latest filing, from 6.41% in the prior quarter.
- Across five years, FCF Margin topped out at 6.41% in Q4 2025 and bottomed at 20320.0% in Q1 2026.
- The 5-year median for FCF Margin is 1725.9% (2025), against an average of 2898.07%.
- The widest annual swing landed in 2025, when FCF Margin jumped 544813 bps; it then slumped 1839281 bps in 2026.
- Tracing OBIO's FCF Margin over 5 years: stood at 797.64% in 2022, then sank by 425 bps to 4187.4% in 2023, then tumbled by 30 bps to 5454.55% in 2024, then surged by 100 bps to 6.41% in 2025, then tumbled by 316710 bps to 20320.0% in 2026.
- Per Business Quant, the three latest OBIO FCF Margin figures stand at 20320.0% (Q1 2026), 6.41% (Q4 2025), and 1725.9% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.17% |
| 10 | Orchestra BioMed Holdings | 245.24 Mn | 255.02 Mn | 78,000.00 | -20,320.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20,320.00% |
| Dec 31, 2025 | -6.41% |
| Sep 30, 2025 | -1,725.90% |
| Jun 30, 2025 | -1,861.36% |
| Mar 31, 2025 | -1,927.19% |
| Dec 31, 2024 | -5,454.55% |
| Sep 30, 2024 | -1,379.13% |
| Jun 30, 2024 | -1,312.85% |
| Mar 31, 2024 | -2,132.42% |
| Dec 31, 2023 | -4,187.40% |
| Sep 30, 2023 | -2,458.47% |
| Jun 30, 2023 | -1,149.40% |
| Mar 31, 2023 | -1,238.49% |
| Dec 31, 2022 | -797.64% |
| Sep 30, 2022 | -643.16% |
| Jun 30, 2022 | -2,052.62% |
| Mar 31, 2022 | -620.21% |